Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2010
05/14/2010WO2010052276A2 A screening assay for insecticides
05/14/2010WO2010052229A1 Hla-g polypeptides and pharmaceutical uses thereof
05/14/2010WO2010052228A1 Hla-g proteins and pharmaceutical uses thereof
05/14/2010WO2010051632A1 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
05/14/2010WO2010033884A3 Method for the treatment of radiation-induced neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant
05/14/2010WO2010033222A3 Polymer conjugates of ziconotide peptides
05/14/2010WO2010033215A3 Polymer conjugates of aod-like peptides
05/14/2010WO2010027857A3 Methods, microorganisms, and compositions for plant biomass processing
05/14/2010WO2010023544A4 Compositions and methods for delivery of protein-coding rnas to correct mitochondrial dysfunction
05/14/2010WO2010022740A3 Hiv-1 envelope polypeptides for hiv vaccine
05/14/2010WO2010018444A3 An expression vector and a method thereof
05/14/2010WO2010010551A3 Angiopoietin derived peptides
05/14/2010WO2009074483A3 Insulinotropic peptide synthesis using solid and solution phase combination techniques
05/14/2010CA2778435A1 Vaccines targeting cellular death receptors
05/14/2010CA2743049A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same
05/14/2010CA2742770A1 Use of inhibitors of plac8 activity for the modulation of adipogenesis
05/14/2010CA2742710A1 Crhr2 peptide agonists and uses thereof
05/14/2010CA2742610A1 Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
05/14/2010CA2742597A1 Modulation of toll-like receptor 4 expression by antisense oligonucleotides
05/14/2010CA2742596A1 Modulation of toll-like receptor 2 expression by antisense oligonucleotides
05/14/2010CA2742531A1 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/14/2010CA2742528A1 Apj receptor compounds
05/14/2010CA2742521A1 Hla-g polypeptides and pharmaceutical uses thereof
05/14/2010CA2742517A1 Hla-g proteins and pharmaceutical uses thereof
05/14/2010CA2742509A1 Cxcr4 receptor compounds
05/14/2010CA2742291A1 Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, andmethods of enrichment, analysis and use
05/14/2010CA2742278A1 Temperature-induced polynucleotides and uses therefor
05/14/2010CA2742086A1 Live, attenuated respiratory syncytial virus
05/14/2010CA2741691A1 Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
05/14/2010CA2741045A1 Novel at1g67330 gene involved in altered nitrate uptake efficiency
05/14/2010CA2740701A1 A screening assay for insecticides
05/14/2010CA2736486A1 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt6 polypeptides and homologs thereof
05/13/2010US20100122384 Nucleic Acid Molecules and Other Molecules Associated with Plants
05/13/2010US20100122382 Cell Cycle Genes and Related Methods
05/13/2010US20100122378 Truncated alternan sucrase coding nucleic acid molecules
05/13/2010US20100122375 Compositions and methods for enhancing disease resistance in plants
05/13/2010US20100122374 Disease resistance in plants by introducing transcription factor gene
05/13/2010US20100122373 Nucleic acid molecules and other molecules associated with plants
05/13/2010US20100122365 Optimizing glycan processing in plants
05/13/2010US20100122357 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies
05/13/2010US20100121039 Methods and compositions for prolonging elimination half-times of bioactive compounds
05/13/2010US20100121038 Template-directed assembly of receptor signaling complexes
05/13/2010US20100121036 Method for the production of insulin-like growth factor-1
05/13/2010US20100121033 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
05/13/2010US20100121032 Long acting proteins and peptides and methods of making and using the same
05/13/2010US20100121031 Membrane-permeant peptide complexes for treatment of sepsis
05/13/2010US20100121030 Antagonism or evasion of soluble cytokine receptors
05/13/2010US20100121029 Anti-hiv immunogenic formulation and process for preparation thereof
05/13/2010US20100121028 Hydrolysable Polymeric FMOC- Linker
05/13/2010US20100121027 Cyclic Peptide Compositions for Treatment of Sexual Dysfunction
05/13/2010US20100120982 Polymer-factor ix moiety conjugates
05/13/2010US20100120700 Methods and compositions for treating cervical cancer
05/13/2010US20100120695 Polypeptides that bind membrane proteins
05/13/2010US20100120690 Polypeptides Having Antimicrobial Activity and Polynucleotides Encoding Same
05/13/2010US20100120689 Polymer factor viii moiety conjugates
05/13/2010US20100120688 ErbB Interface Peptidomimetics And Methods Of Use Thereof
05/13/2010US20100120684 Mutants of interleukin- 1 receptor antagonist and uses thereof
05/13/2010US20100120683 Prame derived peptides and immunogenic compositions comprising these
05/13/2010US20100120681 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization
05/13/2010US20100120680 Method of treating hepatitis c virus
05/13/2010US20100120679 Targeting NBS1-ATM Interaction To Sensitize Cancer Cells To Radiotherapy And Chemotherapy
05/13/2010US20100120678 Novel inhibitors of the egfr kinase targeting the asymmetric activating dimer interface
05/13/2010US20100120677 Activity of recombinant equine follicle stimulating hormone
05/13/2010US20100120675 Inhibitor of the uracil-dna glycosylase enzyme and uses thereof
05/13/2010US20100120673 Bacteriophage lysins for bacillus anthracis
05/13/2010US20100120671 Novel antimicrobial agents
05/13/2010US20100120665 Treatment of diseases characterized by inflammation
05/13/2010US20100120664 Modified coagulation factors with prolonged in vivo half-life
05/13/2010US20100120172 Substance with antithrombotic activity and method for detecting glycokallidin
05/13/2010US20100120153 N-glycosylation mutant of melanoma differentiation associated gene-7
05/13/2010US20100120147 Antagonist of ligands and uses thereof
05/13/2010US20100120143 Induction of apoptosis and cell growth inhibition by protein 4.33
05/13/2010US20100120108 Polypeptides having glucoamylase activity and polynucleotides encoding same
05/13/2010US20100120068 G-protein-conjugated receptor having altered ligand affinity, and use thereof
05/13/2010US20100120052 Orotate Transporter Encoding Marker Genes
05/13/2010US20100120029 Mutagenesis of aspergillus fungi and genes essential for growth
05/13/2010US20100119691 Expression of human milk proteins in transgenic plants
05/13/2010US20100119654 Method for reducing the virus and micro-organism content of biological extracts which contain solids and extract produced according to the method
05/13/2010US20100119575 Osteogenic composite matrix, method for the production thereof and implant and scaffold for tissue engineering provided with a coating formed by said osteogenic composite matrix
05/13/2010US20100119574 Recombinant Gelatins
05/13/2010US20100119553 Helicobacter pylori sialic acid binding adhesin, SabA and sabA - gene
05/13/2010US20100119551 Methods and reagents for vaccination which generate a CD8 T cell immune response
05/13/2010US20100119545 Modified vaccinia ankara virus variant
05/13/2010US20100119544 Vaccine
05/13/2010US20100119538 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
05/13/2010US20100119536 Naturally Processed Measles Virus Peptides From Class II HLA Molecules
05/13/2010US20100119533 Polynucleotides and Polypeptides Identified by IVIAT Screening and Methods of Use
05/13/2010US20100119532 Composition comprising the N-terminal region of histone H2B of Leishmania - use thereof for inducing an immune response
05/13/2010US20100119529 Elastin-like polymer delivery vehicles
05/13/2010US20100119528 Transport of Biologically Active Molecules into a Cell, Mitochondrion, or Nucleus
05/13/2010US20100119524 Adjuvanted vaccine
05/13/2010US20100119521 Compositions and methods for treating cancer by modulating her-2 and egf receptors
05/13/2010US20100119513 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
05/13/2010US20100119507 Streptococcus pyogenes antigens and corresponding dna fragments
05/13/2010US20100119501 Method of delivering a protein into a cell
05/13/2010US20100119495 Human skin equivalents expressing exogenous polypeptides
05/13/2010US20100119491 Dopaminergic neuronal survival-promoting factors and uses thereof
05/13/2010US20100119489 Stimulation of Pancreatic Beta Cell Proliferation
05/13/2010US20100119477 Psm peptides as vaccine targets against methicillin-resistant staphylococcus
05/13/2010US20100119450 Soluble low-density lipoprotein receptor related protein binds directly to alzheimer's amyloid-beta peptide
1 ... 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 ... 2916